Mark Reilly and two other colleagues are also suspected of bribing government officials in Beijing and Shanghai, they said.
Police have handed the case over to prosecutors, officials said.
GSK said it took the allegations "very seriously" and would co-operate with the authorities over the matter.
Chinese authorities announced in July last year that they were investigating GSK, detaining four Chinese GSK executives.
